GSK-LSD1 dihydrochloride is a potent, selective, and irreversible inhibitor of lysine-specific demethylase 1 (LSD1), with an IC50 value of 16 nM; it is used as a histone demethylase inhibitor in epigenetic research and potential therapeutic applications targeting LSD1-related diseases.